BMS Archive

Plant · Scientific monograph

Actaea racemosa

Black cohosh

For educational and scientific research only. Not medical advice. Independently verify claims against the cited primary sources. Consult a qualified healthcare professional before using any plant or fungal preparation.

Research areas: Menopause research, Traditional North American use

Research overview

Historical use

Black cohosh root/rhizome has documented North American traditional use; modern products vary and require authenticated species and preparation [5].

Modern research context

A systematic review found inconsistent results across randomized trials for menopausal symptoms [1]. A 12-month trial found no significant vasomotor-symptom benefit over placebo [2]; a smaller 8-week trial of one root extract cannot settle efficacy for all products [3].

Adverse effects

Liver-injury reports have been described, but causality is uncertain and adulteration/misidentification complicates attribution. A review is not proof that the species caused each case [4,5].

Contraindications

Product identity and extraction method matter; use only authenticated A. racemosa evidence. The available trials do not establish long-term efficacy or safety for all products [1-5].

Clinical and phytochemical data

Used part

Root and rhizome extracts; trial results apply only to the specific extract tested [2,3].

Primary active compounds

  • Triterpene glycosides and phenolic acids are described in phytochemical reviews; commercial-product composition varies [5].

Mechanism of action

Clinical trials do not establish a validated human mechanism for symptom changes [1-3].

Pharmacokinetics

Absorption

Human PK data remain insufficient across products; no general exposure profile is established [1,4].

Distribution

Not characterized consistently for clinical products [1,4].

Metabolism

Not characterized adequately for a general product-specific profile [1,4].

Excretion

Not characterized adequately for a general product-specific profile [1,4].

Safety and interactions

Drug interactions

No interaction profile can be generalized across products from the cited trials; clinically significant interactions remain insufficiently characterized [1,4].

Toxicity

Liver injury has been reported with products labelled black cohosh; causality and product identity are uncertain [4,5].

Special precautions

Pregnancy

Pregnancy safety is not established; use is not supported by the cited menopause trials.

Lactation

Lactation safety is not established.

Hepatic impairment

Given reported liver-injury cases and limited causal certainty, hepatic disease warrants medical review before use; no dose adjustment evidence is established [4].

Renal impairment

Renal impairment data are insufficient.

Sources and references

  1. [1] Francesca Borrelli, Edzard Ernst. Black cohosh (Cimicifuga racemosa) for menopausal symptoms: a systematic review of its efficacy. Pharmacological Research. 2008;58(1):8–14. PMID: 18585461. DOI: 10.1016/j.phrs.2008.05.008.
  2. [2] S. E. Geller et al. Safety and efficacy of black cohosh and red clover for the management of vasomotor symptoms: a randomized controlled trial. Menopause. 2009;16(6):1156–1166. PMID: 19609225. DOI: 10.1097/gme.0b013e3181ace49b.
  3. [3] S. Mohammad-Alizadeh-Charandabi et al. Efficacy of black cohosh (Cimicifuga racemosa L.) in treating early symptoms of menopause: a randomized clinical trial. Chinese Medicine. 2013;8:20. PMID: 24499633. DOI: 10.1186/1749-8546-8-20.
  4. [4] Yuan Le et al. Review of black cohosh-induced toxicity and adverse clinical effects. Journal of Environmental Science and Health, Part C: Toxicology and Carcinogenesis. 2025;43(3):243–268. PMID: 40503925. DOI: 10.1080/26896583.2025.2513795.
  5. [5] Sofia Salari et al. Ethnobotany, Phytochemistry, Traditional and Modern Uses of Actaea racemosa L. (Black cohosh): A Review. Advances in Experimental Medicine and Biology. 2021;1308:403–449. PMID: 33861455. DOI: 10.1007/978-3-030-64872-5_24.

Additional source links

Continue browsing